ESTRO GUIDE 2017

Multidisciplinary Management of Prostate Cancer 21-25 May 2017 Porto, Portugal

TARGET GROUP The course is aimed at radiation oncologists, urologists, medical oncologists and other specialists and trainees who have a special interest in prostate cancer and are willing to update their knowledge. COURSE AIM This 5-day teaching course aims at focusing on the management of localised, locally advanced and meta- static prostate cancer. It emphasises the importance of a multidisciplinary approach and teamwork, where full information exchange is vital to provide the best up- to-date scientific evidence on which the management of the disease will be based. This will be illustrated during state-of-the-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be in- tegrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiation oncologists will also be organised during the course. LEARNINGOUTCOMES • To provide an in-depth overview of the epidemiology, pathology, imaging and treatment options for low, intermediate and high risk prostate cancer • To discuss patient selection/indications and con- tra-indications for the various treatment options • To provide a critical overview of the surgical and radiotherapy techniques available for themanagement of prostate cancer • To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease • To debate on the most recent developments relevant to prostate cancer management.

• Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging • Case discussions. Monday 22 May 2017 • Low risk prostate cancer: active surveillance, surgery and the post-op pathology • Radiotherapy and brachytherapy, the pathology after irradiation • External beam radiotherapy: on-line control, target delineation • Case discussions. Tuesday 23 May 2017 • High risk prostate cancer: radiotherapy and hormones, alternative radiotherapy regimens • Toxicity of radiotherapy: acute and late morbidity – erectile dysfunction • Role of surgery and its morbidity • Alternative treatments • Case discussions and Journal Club. Wednesday 24 May 2017 • Adjuvant and salvage radiotherapy after radical surgery • Rising PSA after surgery and after radiotherapy • Imaging for recurrent detection • Node positive prostate cancer • Case discussions and Journal Club. Thursday 25 May 2017 • Metastatic prostate cancer: hormones and their complications • Castration resistant prostate cancer: new drugs • Palliative radiotherapy and surgery • Non systemic treatment in the metastatic setting. PREREQUISITES Before commencing this course participants should: • Revise the general principles of prostate cancer epi- demiology, pathology, diagnosis and staging • Read the published ESTRO and ASTRO guidelines on prostate contouring and the EAU (European As- sociation of Urology) guidelines on prostate cancer

COURSE CONTENT Sunday 21 May 2017 • Normal prostate: anatomy – embryology, histology

50

ESTRO SCHOOL